Cart
sales@molnova.com
UNC3866 TFA(1872382-47-2 free base)
CAS No. 1872382-48-3
UNC3866 TFA(1872382-47-2 free base)( —— )
Catalog No. M23852 CAS No. 1872382-48-3
UNC3866 TFA is a potent antagonist of the CBX7-H3 interaction as determined by AlphaScreen.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 68 | In Stock |
|
| 5MG | 102 | In Stock |
|
| 10MG | 183 | In Stock |
|
| 25MG | 360 | In Stock |
|
| 50MG | 536 | In Stock |
|
| 100MG | 764 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameUNC3866 TFA(1872382-47-2 free base)
-
NoteResearch use only, not for human use.
-
Brief DescriptionUNC3866 TFA is a potent antagonist of the CBX7-H3 interaction as determined by AlphaScreen.
-
DescriptionUNC3866 TFA is a potent antagonist of the CBX7-H3 interaction as determined by AlphaScreen.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetHistone Demethylase
-
RecptorCBX7-H3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1872382-48-3
-
Formula Weight909.04
-
Molecular FormulaC45H67F3N6O10
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCCN(CC)CCCC[C@@H](C(=O)N[C@@H](CO)C(=O)OC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=CC=C(C=C2)C(C)(C)C.C(=O)(C(F)(F)F)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Stuckey JI, et al. A cellular chemical probe targeting the chromodomains of Polycomb repressive complex 1. Nat Chem Biol. 2016 Mar;12(3):180-7.
molnova catalog
related products
-
IOX1
IOX1 is a potent, broad-spectrum inhibitor of 2OG oxygenases, including the JmjC demethylases.
-
EZM0414
EZM0414 is a selective SEDT2 inhibitor that is mostly used to study diffuse large B lymphocytoma and recurrent or refractory multiple myeloma.
-
AS-8351
AS-8351 (NSC 51355) is a small molecule that induces reprogramming of human fetal lung fibroblasts into functional cardiomyocytes.
